133 related articles for article (PubMed ID: 24007859)
1. Nonpeptidic angiotensin II AT₁ receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.
Zhang J; Wang JL; Yu WF; Zhou ZM; Tao WC; Wang YC; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
Eur J Med Chem; 2013 Nov; 69():44-54. PubMed ID: 24007859
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.
Zhang J; Wang JL; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
Bioorg Med Chem; 2012 Jul; 20(14):4208-16. PubMed ID: 22727371
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center.
Han XF; He X; Wang M; Xu D; Hao LP; Liang AH; Zhang J; Zhou ZM
Eur J Med Chem; 2015 Oct; 103():473-87. PubMed ID: 26397395
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of AT
Wu Z; Anh NTP; Yan YJ; Xia MB; Wang YH; Qiu Y; Chen ZL
Eur J Med Chem; 2019 Nov; 181():111553. PubMed ID: 31369932
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
Vyas VK; Gupta N; Ghate M; Patel S
SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
[TBL] [Abstract][Full Text] [Related]
8. In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies.
Ojima M; Igata H; Tanaka M; Sakamoto H; Kuroita T; Kohara Y; Kubo K; Fuse H; Imura Y; Kusumoto K; Nagaya H
J Pharmacol Exp Ther; 2011 Mar; 336(3):801-8. PubMed ID: 21123673
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome.
Mizuno CS; Chittiboyina AG; Shah FH; Patny A; Kurtz TW; Pershadsingh HA; Speth RC; Karamyan VT; Carvalho PB; Avery MA
J Med Chem; 2010 Feb; 53(3):1076-85. PubMed ID: 20073471
[TBL] [Abstract][Full Text] [Related]
10. The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.
Agelis G; Resvani A; Durdagi S; Spyridaki K; Tůmová T; Slaninová J; Giannopoulos P; Vlahakos D; Liapakis G; Mavromoustakos T; Matsoukas J
Eur J Med Chem; 2012 Sep; 55():358-74. PubMed ID: 22889560
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.
Casimiro-Garcia A; Heemstra RJ; Bigge CF; Chen J; Ciske FA; Davis JA; Ellis T; Esmaeil N; Flynn D; Han S; Jalaie M; Ohren JF; Powell NA
Bioorg Med Chem Lett; 2013 Feb; 23(3):767-72. PubMed ID: 23265881
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.
Berellini G; Cruciani G; Mannhold R
J Med Chem; 2005 Jun; 48(13):4389-99. PubMed ID: 15974591
[TBL] [Abstract][Full Text] [Related]
13. 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.
Ries UJ; Mihm G; Narr B; Hasselbach KM; Wittneben H; Entzeroth M; van Meel JC; Wienen W; Hauel NH
J Med Chem; 1993 Dec; 36(25):4040-51. PubMed ID: 8258826
[TBL] [Abstract][Full Text] [Related]
14. Unique "delta lock" structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor.
Ohno K; Amano Y; Kakuta H; Niimi T; Takakura S; Orita M; Miyata K; Sakashita H; Takeuchi M; Komuro I; Higaki J; Horiuchi M; Kim-Mitsuyama S; Mori Y; Morishita R; Yamagishi S
Biochem Biophys Res Commun; 2011 Jan; 404(1):434-7. PubMed ID: 21130741
[TBL] [Abstract][Full Text] [Related]
15. 3D QSAR studies on substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist.
Vyas VK; Ghate M; Chintha C; Patel P
Curr Comput Aided Drug Des; 2013 Sep; 9(3):433-45. PubMed ID: 24010938
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.
Xu JY; Zeng Y; Ran Q; Wei Z; Bi Y; He QH; Wang QJ; Hu S; Zhang J; Tang MY; Hua WY; Wu XM
Bioorg Med Chem Lett; 2007 May; 17(10):2921-6. PubMed ID: 17412584
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists.
Bali A; Bansal Y; Sugumaran M; Saggu JS; Balakumar P; Kaur G; Bansal G; Sharma A; Singh M
Bioorg Med Chem Lett; 2005 Sep; 15(17):3962-5. PubMed ID: 16039125
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities.
Zhu W; Da Y; Wu D; Zheng H; Zhu L; Wang L; Yan Y; Chen Z
Bioorg Med Chem; 2014 Apr; 22(7):2294-302. PubMed ID: 24613628
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel potent angiotensin II receptor antagonists with anti-hypertension effect.
Nie YY; Da YJ; Zheng H; Yang XX; Jia L; Wen CH; Liang LS; Tian J; Chen ZL
Bioorg Med Chem; 2012 Apr; 20(8):2747-61. PubMed ID: 22410249
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists.
Kim TW; Yoo BW; Lee JK; Kim JH; Lee KT; Chi YH; Lee JY
Bioorg Med Chem Lett; 2012 Feb; 22(4):1649-54. PubMed ID: 22264484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
